CDSCO UID IMP/IVD/2020/001094_e63caf703bc2cbeb9c039d8fe55c9312_673a878f8f4b00ad35e62d309c8c8067
Beta-2-Microglobulin/Cystatin C Reagent Kit
PTS Diagnostics India Private Limited·Device Class Class B·India CDSCO
Registration details
- UID
- IMP/IVD/2020/001094_e63caf703bc2cbeb9c039d8fe55c9312_673a878f8f4b00ad35e62d309c8c8067
- Device class
- Class B
- License holder
- PTS Diagnostics India Private Limited
- Approving authority
- CDSCO
- Product information
- The β2-Microglobulin/Cystatin C Reagent Kit is intended to quantitatively determine β2-microglobulin and cystatin C in human serum. Clinically, it is mainly used for auxiliary diagnosis of renal diseases
Other products from PTS Diagnostics India Private Limited
Products from the same license holder (10 products)
Arm Type Electronic Blood Pressure Monitor
Brand: Sinocare
Class B
C-Reactive Protein Reagent Kit
Class B
C-Reactive Protein/Serum Amyloid A Reagent Kit
Class B
Urea/Creatinine/Uric Acid Reagent Kit
Class B
Alanine Aminotransferase/Aspartate Aminotransferase/Total Bilirubin/Albumin Reagent Kit
Class B
Glycated Hemoglobin Reagent Kit
Brand: capillary
Class B
Blood Lipid Reagent Kit
Brand: capillary
Class B
1,5-Anhydro-D-Sorbitol Reagent Kit
Class B
APTT/PT/TT/FIB Reagent Kit
Brand: PT
Class C
Prothrombin Time Reagent Kit
Class C
About this record
Beta-2-Microglobulin/Cystatin C Reagent Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001094_e63caf703bc2cbeb9c039d8fe55c9312_673a878f8f4b00ad35e62d309c8c8067. The license holder is PTS Diagnostics India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.